4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000082
Chief Medical Officer sold 2,349 shares at $14.79 ($34,742)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffner Michael Chief Medical Officer | 2025-04-23 | Sale | −2,349 | $14.79 | $34,742 | 225,370 | D |
| Open-market sales · 2,349 sh · avg $14.79 · $34,742 | |||||||
Loading xslF345X05/wk-form4_1745612149.xml…